.
So…. Would you really sell in May and go away? It is tempting to follow this saying after such a great start to this year. Believe it or not, there are still some great opportunities on the market. As the Q2 earnings season is starting, the market once again has its fair share of nervous […]
The last 12 months have been quite interesting, to say the least. We reached an all-time high (once again) right before getting hit by a quick storm that ended on Christmas Eve. As we are about to enter the second earnings season of the year, the first to report 2019 numbers, it’s time to look […]
Summary Merging with Praxair to become a $90B leader. Operating margin and profits increasing, bringing positive outlook for 2019 Several months ago, Linde plc (LIN) announced its to become a massive player in the gas industry with Praxair The business has done relatively well in the past quarters with profit increasing, pleasing investors. Historically, LIN […]
Summary Favorable Q4 figures bring out optimism amongst investors New acquisitions and a new joint venture with Pfizer could lead to something huge Higher-than-average yield also comes with its share of uncertainty GlaxoSmithKline (GSK) has built over the years a pharmaceutical empire. R&D numbers reaching billions, new discoveries leading to newly marketed products as well […]
Summary Q4 figures give an overview of the company’s satisfying position Acquisitions seem to be a winning formula for healthy margins While not alarming, uncertainties start to rise on multiple levels With everything a consumer buys, it’s easy to forget about the “little things”. But those so-called little things, are often essential components to many […]
Receive dividend stock ideas and exclusive investing strategies with this dividend stock newsletter.
No cost, just content.
